List of Tables
Table 1. Global Anti-Infective Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Live/attenuated Vaccines
Table 5. Global Anti-Infective Vaccines Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Anti-Infective Vaccines Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Anti-Infective Vaccines Sales by Regions (2016-2021) & (K Units)
Table 8. Global Anti-Infective Vaccines Sales Market Share by Regions (2016-2021)
Table 9. Global Anti-Infective Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Anti-Infective Vaccines Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Anti-Infective Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Anti-Infective Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Anti-Infective Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Anti-Infective Vaccines Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Anti-Infective Vaccines Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Anti-Infective Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 17. Anti-Infective Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Anti-Infective Vaccines Revenue Share by Manufacturers (2016-2021)
Table 19. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Vaccines as of 2020)
Table 21. Key Manufacturers Anti-Infective Vaccines Price (2016-2021) (US$/Unit)
Table 22. Anti-Infective Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Anti-Infective Vaccines Product Type
Table 24. Date of International Manufacturers Enter into Anti-Infective Vaccines Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-Infective Vaccines Sales by Type (2016-2021) (K Units)
Table 27. Global Anti-Infective Vaccines Sales Share by Type (2016-2021)
Table 28. Global Anti-Infective Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Anti-Infective Vaccines Revenue Share by Type (2016-2021)
Table 30. Anti-Infective Vaccines Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 31. Global Anti-Infective Vaccines Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Anti-Infective Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Anti-Infective Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Anti-Infective Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Anti-Infective Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Anti-Infective Vaccines Sales by Application (2016-2021) (K Units)
Table 37. Global Anti-Infective Vaccines Sales Share by Application (2016-2021)
Table 38. Global Anti-Infective Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Anti-Infective Vaccines Revenue Share by Application (2016-2021)
Table 40. Anti-Infective Vaccines Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 41. Global Anti-Infective Vaccines Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Anti-Infective Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Anti-Infective Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Anti-Infective Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Anti-Infective Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 46. China Anti-Infective Vaccines Sales (K Units) of Key Companies (2016-2021)
Table 47. China Anti-Infective Vaccines Sales Share by Company (2016-2021)
Table 48. China Anti-Infective Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 49. China Anti-Infective Vaccines Revenue Share by Company (2016-2021)
Table 50. China Anti-Infective Vaccines Sales (K Units) by Type (2016-2021)
Table 51. China Anti-Infective Vaccines Sales Share by Type (2016-2021)
Table 52. China Anti-Infective Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Anti-Infective Vaccines Price (US$/Unit) by Type (2016-2021)
Table 54. China Anti-Infective Vaccines Sales (K Units) by Type (2022-2027)
Table 55. China Anti-Infective Vaccines Sales Share by Type (2022-2027)
Table 56. China Anti-Infective Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Anti-Infective Vaccines Revenue Share by Type (2022-2027)
Table 58. China Anti-Infective Vaccines Price (US$/Unit) by Type (2022-2027)
Table 59. China Anti-Infective Vaccines Sales (K Units) by Application (2016-2021)
Table 60. China Anti-Infective Vaccines Sales Share by Application (2016-2021)
Table 61. China Anti-Infective Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Anti-Infective Vaccines Price (US$/Unit) by Application (2016-2021)
Table 63. China Anti-Infective Vaccines Sales (K Units) by Application (2022-2027)
Table 64. China Anti-Infective Vaccines Sales Share by Application (2022-2027)
Table 65. China Anti-Infective Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Anti-Infective Vaccines Revenue Share by Application (2022-2027)
Table 67. China Anti-Infective Vaccines Price (US$/Unit) by Application (2022-2027)
Table 68. North America Anti-Infective Vaccines Sales by Country (2016-2021) & (K Units)
Table 69. North America Anti-Infective Vaccines Sales Market Share by Country (2016-2021)
Table 70. North America Anti-Infective Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Anti-Infective Vaccines Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Anti-Infective Vaccines Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Anti-Infective Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region (2016-2021)
Table 76. Europe Anti-Infective Vaccines Sales by Country (2016-2021) & (K Units)
Table 77. Europe Anti-Infective Vaccines Sales Market Share by Country (2016-2021)
Table 78. Europe Anti-Infective Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Anti-Infective Vaccines Revenue Market Share by Country (2016-2021)
Table 80. Latin America Anti-Infective Vaccines Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Anti-Infective Vaccines Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Anti-Infective Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Anti-Infective Vaccines Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Anti-Infective Vaccines Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Anti-Infective Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Country (2016-2021)
Table 88. Emergent BioDefense Operations Lansing Inc. Corporation Information
Table 89. Emergent BioDefense Operations Lansing Inc. Description and Business Overview
Table 90. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product
Table 92. Emergent BioDefense Operations Lansing Inc. Recent Development
Table 93. Sanofi Pasteur Corporation Information
Table 94. Sanofi Pasteur Description and Business Overview
Table 95. Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Sanofi Pasteur Product
Table 97. Sanofi Pasteur Recent Development
Table 98. Merck & Co. Corporation Information
Table 99. Merck & Co. Description and Business Overview
Table 100. Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Merck & Co. Product
Table 102. Merck & Co. Recent Development
Table 103. MedImmune LLC Corporation Information
Table 104. MedImmune LLC Description and Business Overview
Table 105. MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. MedImmune LLC Product
Table 107. MedImmune LLC Recent Development
Table 108. Novartis Vaccines Corporation Information
Table 109. Novartis Vaccines Description and Business Overview
Table 110. Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Novartis Vaccines Product
Table 112. Novartis Vaccines Recent Development
Table 113. Diagnostics Ltd. Corporation Information
Table 114. Diagnostics Ltd. Description and Business Overview
Table 115. Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Diagnostics Ltd. Product
Table 117. Diagnostics Ltd. Recent Development
Table 118. Intercell Biomedical Corporation Information
Table 119. Intercell Biomedical Description and Business Overview
Table 120. Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Intercell Biomedical Product
Table 122. Intercell Biomedical Recent Development
Table 123. MassBiologics Corporation Information
Table 124. MassBiologics Description and Business Overview
Table 125. MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. MassBiologics Product
Table 127. MassBiologics Recent Development
Table 128. Barr Labs, Inc. Corporation Information
Table 129. Barr Labs, Inc. Description and Business Overview
Table 130. Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Barr Labs, Inc. Product
Table 132. Barr Labs, Inc. Recent Development
Table 133. Organon Teknika Co. Corporation Information
Table 134. Organon Teknika Co. Description and Business Overview
Table 135. Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Organon Teknika Co. Product
Table 137. Organon Teknika Co. Recent Development
Table 138. GlaxoSmithKline Biologicals Corporation Information
Table 139. GlaxoSmithKline Biologicals Description and Business Overview
Table 140. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. GlaxoSmithKline Biologicals Product
Table 142. GlaxoSmithKline Biologicals Recent Development
Table 143. CSL Ltd. Corporation Information
Table 144. CSL Ltd. Description and Business Overview
Table 145. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. CSL Ltd. Product
Table 147. CSL Ltd. Recent Development
Table 148. ID Biomedical Co. Corporation Information
Table 149. ID Biomedical Co. Description and Business Overview
Table 150. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. ID Biomedical Co. Product
Table 152. ID Biomedical Co. Recent Development
Table 153. Protein Sciences Co. Corporation Information
Table 154. Protein Sciences Co. Description and Business Overview
Table 155. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 156. Protein Sciences Co. Product
Table 157. Protein Sciences Co. Recent Development
Table 158. Wyeth Pharmaceuticals, Inc. Corporation Information
Table 159. Wyeth Pharmaceuticals, Inc. Description and Business Overview
Table 160. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 161. Wyeth Pharmaceuticals, Inc. Product
Table 162. Wyeth Pharmaceuticals, Inc. Recent Development
Table 163. Berna Biotech Corporation Information
Table 164. Berna Biotech Description and Business Overview
Table 165. Berna Biotech Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 166. Berna Biotech Product
Table 167. Berna Biotech Recent Development
Table 168. Anti-Infective Vaccines Market Trends
Table 169. Anti-Infective Vaccines Market Drivers
Table 170. Anti-Infective Vaccines Market Challenges
Table 171. Anti-Infective Vaccines Market Restraints
Table 172. Anti-Infective Vaccines Customers List
Table 173. Anti-Infective Vaccines Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Infective Vaccines Product Picture
Figure 2. Global Anti-Infective Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. Inactivated Vaccines Product Picture
Figure 4. Conjugate Vaccines Product Picture
Figure 5. Live/attenuated Vaccines Product Picture
Figure 6. Global Anti-Infective Vaccines Sales Market Share by Application in 2020 & 2027
Figure 7. Bacterial Diseases
Figure 8. Viral Diseases
Figure 9. Anti-Infective Vaccines Report Years Considered
Figure 10. Global Anti-Infective Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Anti-Infective Vaccines Market Size 2016-2027 (US$ Million)
Figure 12. Global Anti-Infective Vaccines Sales 2016-2027 (K Units)
Figure 13. Global Anti-Infective Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Anti-Infective Vaccines Sales Market Share by Region (2016-2021)
Figure 15. Global Anti-Infective Vaccines Sales Market Share by Region in 2020
Figure 16. Global Anti-Infective Vaccines Revenue Market Share by Region (2016-2021)
Figure 17. Global Anti-Infective Vaccines Revenue Market Share by Region in 2020
Figure 18. Global Anti-Infective Vaccines Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Anti-Infective Vaccines Revenue in 2020
Figure 20. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Anti-Infective Vaccines Sales Market Share by Type (2016-2021)
Figure 22. Global Anti-Infective Vaccines Sales Market Share by Type in 2020
Figure 23. Global Anti-Infective Vaccines Revenue Market Share by Type (2016-2021)
Figure 24. Global Anti-Infective Vaccines Revenue Market Share by Type in 2020
Figure 25. Global Anti-Infective Vaccines Sales Market Share by Application (2016-2021)
Figure 26. Global Anti-Infective Vaccines Sales Market Share by Application in 2020
Figure 27. Global Anti-Infective Vaccines Revenue Market Share by Application (2016-2021)
Figure 28. Global Anti-Infective Vaccines Revenue Market Share by Application in 2020
Figure 29. China Anti-Infective Vaccines Sales Growth Rate 2016-2027 (K Units)
Figure 30. China Anti-Infective Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Anti-Infective Vaccines Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Anti-Infective Vaccines Players Market Share by Revenue in Anti-Infective Vaccines in 2020
Figure 33. China Anti-Infective Vaccines Revenue Share by Type (2016-2021)
Figure 34. China Anti-Infective Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Anti-Infective Vaccines Revenue Share by Application (2016-2021)
Figure 36. China Anti-Infective Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Anti-Infective Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America Anti-Infective Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Anti-Infective Vaccines Sales Market Share by Country in 2020
Figure 40. North America Anti-Infective Vaccines Revenue Market Share by Country in 2020
Figure 41. U.S. Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 42. U.S. Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Anti-Infective Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe Anti-Infective Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Anti-Infective Vaccines Sales Market Share by Country in 2020
Figure 48. Europe Anti-Infective Vaccines Revenue Market Share by Country in 2020
Figure 49. Germany Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 52. France Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 54. U.K. Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 58. Russia Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Anti-Infective Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 60. Asia Pacific Anti-Infective Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region in 2020
Figure 62. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region in 2020
Figure 63. China Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 64. China Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 66. Japan Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 68. South Korea Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 70. India Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 72. Australia Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 74. Taiwan Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 76. Indonesia Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 78. Thailand Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 80. Malaysia Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 82. Philippines Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 84. Vietnam Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Anti-Infective Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 86. Latin America Anti-Infective Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Anti-Infective Vaccines Sales Market Share by Country in 2020
Figure 88. Latin America Anti-Infective Vaccines Revenue Market Share by Country in 2020
Figure 89. Mexico Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 90. Mexico Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 92. Brazil Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 94. Argentina Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Anti-Infective Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 96. Middle East and Africa Anti-Infective Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Country in 2020
Figure 99. Turkey Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 100. Turkey Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 102. Saudi Arabia Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. UAE Anti-Infective Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 104. UAE Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Anti-Infective Vaccines Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
